期刊文献+

老年人复发卵巢癌的临床病理特点分析 被引量:4

Analysis of clinical pathological characteristics of senile recurrent ovarian cancer
原文传递
导出
摘要 目的 分析老年人复发卵巢癌的临床病理特点及对预后的影响。方法 140例老年卵巢癌患者按复发情况将卵巢癌复发患者103例归为观察组,将其余卵巢癌未复发患者37例归为对照组,比较两组患者首次入院后癌组织病理特点,并分析观察组患者复发入院后癌组织病理特点,综合分析两组老年卵巢癌患者预后情况与其临床病理特点。结果 观察组癌组织分期中处低分化的患者数和病理分期在处M的患者数均明显高于对照组(χ2=13.48、15.87,均P<0.05)。除中枢神经毒性外,观察组不良反应发生率明显高于对照组(χ2=13.8、11.6、14.5、13.9、14.9、13.4,均P<0.05)。结论 老年卵巢癌的临床病理特点在一定程度上可以反映患者预后情况,对于患者病情的复发和预后评定有一定临床价值。 Objective To discuss and analyze clinical pathological characteristics of senile recurrent ovarian cancer and its influences on prognosis.Methods 140 senile ovarian cancer patients who have been admitted in our hospital were selected as study subjects.103 cases with recurrent ovarian cancer were selected as observation group (group A),and the rest 37 cases who did not suffer from recurrent ovarian cancer were selected as control group (group B).Pathological characteristics of carcinoma tissues after their first admission in our hospital were compared between the two groups.And pathological characteristics of carcinoma tissues of group A after their second admission in our hospital were analyzed,comprehensively analyzed prognosis situations and clinical pathological characteristics of patients in these two groups.Results In group A,the number of poorly differentiated carcinoma tissues was obviously more than group B,and the number of patients whose neoplasm staging was M stage was more than that in group B,the differences between the two groups were significant(χ2=13.48,15.87,all P〈0.05).The incidence rate of adverse reactions between the two groups also had statistical significance(χ2=13.8,11.6,14.5,13.9,14.9,13.4,all P〈0.05).Conclusion The clinical pathological characteristics of senile recurrent ovarian cancer can reflect patients′ prognosis situations in some degree,and has certain clinical value in evaluation of patients′ disease recurrence and prognosis.
出处 《中国基层医药》 CAS 2013年第12期1826-1827,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 卵巢肿瘤 病理学 临床 老年人 Ovarian neoplasms Pathology,clinical Aged
  • 相关文献

参考文献10

二级参考文献83

  • 1陈艳,叶大风,谢幸.血清CA125测定在上皮性卵巢癌病情监测中的作用[J].国外医学(计划生育分册),2005,24(2):90-94. 被引量:6
  • 2朱笕青,高永良,陈雅卿,陈鲁,刘兰芳.吉西他滨加顺铂治疗复发性卵巢癌[J].中国癌症杂志,2005,15(2):173-175. 被引量:7
  • 3刘军.艾素联合异环磷酰胺治疗复发性卵巢上皮癌近期疗效观察[J].中国肿瘤临床与康复,2005,12(5):417-418. 被引量:1
  • 4Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer, 1997, 80: 1273-1283.
  • 5Wright JD, Herzog TJ, Powell MA. Morbidity of cytoreductive surgery in the elderly. Am J Obstet Gynecol, 2004: 190:1398-1400.
  • 6Gol M, Saygili U, Saatll B, et al. Should advanced age alone be considered a contraindication to systemic lymphadenectomy in gynecologic oncologic patients? A university hospital experience in Turkey. Int J Gynecol Cancer, 2004, 14:508-514.
  • 7Ginannice R, Susini T, Ferrandina G, et al. Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients. Cancer, 2001, 92: 2562-2568.
  • 8Hershman D, Fleischauer AT, Jacobson JS, et al. Patterns and outcomes of chemotherapy for elderly patients with stage Ⅱ ovarian cancer: a population-based study. Gynecol Oncol, 2004, 92:293-299.
  • 9Villella JA, Chaudhry T, Pearl ML, et al. Comparison of tolerance of combination carboplatin and paclitaxel chemotherapy by age in women with ovarian cancer. Gynecol Oncol, 2002, 86:316-322.
  • 10Ceccaroni M, D'Agonstino G, Ferrandina G, et al. Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study. Hynecol Oncol, 2002, 85: 445-450.

共引文献103

同被引文献39

  • 1褚艳侠,郑艾.上皮性卵巢癌生物学预后相关因素[J].西部医学,2006,18(3):371-373. 被引量:1
  • 2崔明,徐海,杨彦.Pokemon蛋白在乳腺癌中的表达及意义[J].临床外科杂志,2007,15(6):399-401. 被引量:23
  • 3du Bois A, Reuss A, Pujade - Lauraine E, etal. Role of surgi- cal outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively ran- domized phase 3 multicenter trials [J]. Cancer, 2009, 115(6): 1234-1244.
  • 4Janssen-Heijnen M L G, Gondos A, Bray F, etal. Clinical rele- vance of conditional survival of cancer patients in Europe: age- specific analyses of 13 cancers [J]. Journal of Clinical Oncology, 2010, 28(15): 2520-2528.
  • 5Mackay H J, Brady M F, Oza A M, etal. Prognostic relevance of uncommon ovarian histology in women with stage Ⅲ/Ⅳ epi- thelial ovarian cancer [J]. International journal of gynecological cancer, 2010, 20(6): 945-952.
  • 6Jorgensen T L, Teiblum S, Paludan M, et al. Significance of age and comorbidity on treatment modality, treatment adher- ence, and prognosis in elderly ovarian cancer patients I-J]. Gy- necologic oncology, 2012, 2(14) : 74-79.
  • 7王志梅,张凡,张九鸿,等.老年卵巢癌MGMT,GST-Ⅱ,HIF-1⒈表达与临床预后关系的组织芯片研究[J].中国美容医学,2011,20(4):314-319.
  • 8Jorgensen T L, Teiblum S, Paludan M et al. Significance of age and eomorbidity on treatment modality, treatment adher- ence, and prognosis in elderly ovarian cancer patients [J]. Gy- necologic oneology, 2012, 25(3) 322-328.
  • 9Ueda T, Volinia S, Okumura H, et al. Relation between mi- croRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis [J]. The lancet oncolo- gy, 2010, 11(2): 136-146.
  • 10Rustin GJ S, van der Burg M E L, Griffin C L, etal. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955)z a randomised trial [J]. The Lancet, 2010, 376(9747): 1155-1163.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部